Human monocyte activation by biologic and biodegradable meshes in vitro

Surgical Endoscopy

Volumn 24, Issue 4, 2010, Pages 805-811

  Orenstein, Sean B ^a   Qiao, Yi ^b   Kaur, Manjot ^b   Klueh, Ulrike ^a,b   Kreutzer, Don L ^a,b   Novitsky, Yuri W ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

Biologic mesh; Cytokine; Growth factor; Human dermis; Monocyte macrophage; Mononuclear cells

Indexed keywords

CYTOKINE; GROWTH FACTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; VASCULOTROPIN;

ARTICLE; BIODEGRADABILITY; CELL ACTIVATION; CONTROLLED STUDY; HERNIOPLASTY; HUMAN; HUMAN CELL; INCUBATION TIME; INFLAMMATION; MACROPHAGE ACTIVATION; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURGICAL EQUIPMENT;

EID: 77952549553     PISSN: 09302794     EISSN: 14322218     Source Type: Journal    
DOI: 10.1007/s00464-009-0664-3     Document Type: Article

References (38)

1. Gray SH, Hawn MT, Itani KM (2008) Surgical progress in inguinal and ventral incisional hernia repair. Surg Clin North Am 88:17-26, vii
2. Rutkow IM (2003) Demographic and socioeconomic aspects of hernia repair in the United States in 2003. Surg Clin North Am 83:1045-1051, v-vi
3. Kingsnorth A, LeBlanc K (2003) Hernias: inguinal and incisional. Lancet 362:1561-1571
4. Bachman S, Ramshaw B (2008) Prosthetic material in ventral hernia repair: how do I choose? Surg Clin NorthAm88:101-112, ix
5. Udwadia T (2006) Inguinal hernia repair: the total picture. J Min Access Surg 2:144-146
6. Jin J, Rosen MJ, Blatnik J, McGee MF, Williams CP, Marks J, Ponsky J (2007) Use of acellular dermal matrix for complicated ventral hernia repair: does technique affect outcomes? J Am Coll Surg 205:654-660
7. Milburn ML, Holton LH, Chung TL, Li EN, Bochicchio GV, Goldberg NH, Silverman RP (2008) Acellular dermal matrix compared with synthetic implant material for repair of ventral hernia in the setting of perioperative Staphylococcus aureus implant contamination: a rabbit model. Surg Infect Larchmt 9:433-442
8. Saettele TM, Bachman SL, Costello CR, Grant SA, Cleveland DS, Loy TS, Kolder DG, Ramshaw BJ (2007) Use of porcine dermal collagen as a prosthetic mesh in a contaminated field for ventral hernia repair: a case report. Hernia 11:279-285
9. Hiles M, Record Ritchie RD, Altizer AM (2009) Are biologic grafts effective for hernia repair? A systematic review of the literature. Surg Innov 16:26-37
10. Schuster R, Singh J, Safadi BY, Wren SM (2006) The use of acellular dermal matrix for contaminated abdominal wall defects: wound status predicts success. Am J Surg 192:594-597
11. Shaikh FM, Giri SK, Durrani S, Waldron D, Grace PA (2007) Experience with porcine acellular dermal collagen implant in one-stage tension-free reconstruction of acute and chronic abdominal wall defects. World J Surg 31:1966-1972; discussion 1973-1964, 1975
12. Bellows CF, Albo D, Berger DH, Awad SS (2007) Abdominal wall repair using human acellular dermis. Am J Surg 194:192-198
13. Badylak SF (2004) Xenogeneic extracellular matrix as a scaffold for tissue reconstruction. Transpl Immunol 12:367-377
14. Badylak SF, Valentin JE, Ravindra AK, McCabe GP, Stewart- Akers AM (2008) Macrophage phenotype as a determinant of biologic scaffold remodeling. Tissue Eng Part A 14:1835-1842
15. Gordon S, Taylor PR (2005) Monocyte and macrophage heterogeneity. Nat Rev Immunol 5:953-964
16. Schachtrupp A, Klinge U, Junge K, Rosch R, Bhardwaj RS, SchumpelickV(2003) Individual inflammatory response of human blood monocytes to mesh biomaterials. Br J Surg 90:114-120
17. Schutte RJ, Parisi-Amon A, Reichert WM (2009) Cytokine profiling using monocytes/macrophages cultured on common biomaterials with a range of surface chemistries. J Biomed Mater Res A 88:128-139
18. Orenstein S, Kaur M, Klueh U, Kreutzer D, Novitsky Y (2009) Activation of human monocytes by human biologic meshes in vitro (abstract). J Surg Res 151:290
19. Butler CE (2006) The role of bioprosthetics in abdominal wall reconstruction. Clin Plast Surg 33:199-211, v-vi
20. Jansen PL, Mertens Pr P, Klinge U, Schumpelick V (2004) The biology of hernia formation. Surgery 136:1-4
21. Sandor M, Xu H, Connor J, Lombardi J, Harper JR, Silverman RP, McQuillan DJ (2008) Host response to implanted porcinederived biologic materials in a primate model of abdominal wall repair. Tissue Eng Part A 14:2021-2031
22. Xu H, Wan H, Sandor M, Qi S, Ervin F, Harper JR, Silverman RP, McQuillan DJ (2008) Host response to human acellular dermal matrix transplantation in a primate model of abdominal wall repair. Tissue Eng Part A 14:2009-2019
23. Kaback LA, Smith TJ (1999) Expression of hyaluronan synthase messenger ribonucleic acids and their induction by interleukin-1 beta in human orbital fibroblasts: potential insight into the molecular pathogenesis of thyroid-associated ophthalmopathy. J Clin Endocrinol Metab 84:4079-4084
24. Oncul O, Yildiz S, Gurer US, Yeniiz E, Qyrdedi T, Top C, Gocer P, Akarsu B, Cevikbas A, Cavuslu S (2007) Effect of the function of polymorphonuclear leukocytes and interleukin-1 beta on wound healing in patients with diabetic foot infections. J Infect 54:250-256
25. Yamada Y, Itano N, Hata K, Ueda M, Kimata K (2004) Differential regulation by IL-1 beta and EGF of expression of three different hyaluronan synthases in oral mucosal epithelial cells and fibroblasts and dermal fibroblasts: quantitative analysis using real-time RT-PCR. J Invest Dermatol 122:631-639
26. Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M (2008) Growth factors and cytokines in wound healing. Wound Repair Regen 16:585-601
27. Barton BE (1997) IL-6: insights into novel biological activities. Clin Immunol Immunopathol 85:16-20
28. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Muller-Newen G, Schaper F (2003) Principles of interleukin (IL)-6-type cytokine signaling and its regulation. Biochem J 374:1-20
29. Sunderkotter C, Steinbrink K, Goebeler M, Bhardwaj R, Sorg C (1994) Macrophages and angiogenesis. J Leukoc Biol 55:410-422
30. NovitskyYW,Litwin DE, CalleryMP(2004) The net immunologic advantage of laparoscopic surgery. Surg Endosc 18:1411-1419
31. Labler L, Rancan M, Mica L, Harter L, Mihic-Probst D, Keel M (2009) Vacuum-assisted closure therapy increases local interleukin-8 and vascular endothelial growth factor levels in traumatic wounds. J Trauma 66:749-757
32. Mukaida N, Harada A, Matsushima K (1998) Interleukin-8 (IL-8) and monocyte chemotactic and activating factor (MCAF/MCP-1), chemokines essentially involved in inflammatory and immune reactions. Cytokine Growth Factor Rev 9:9-23
33. Berse B, Brown LF, Van de Water L, Dvorak HF, Senger DR (1992) Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell 3:211-220
34. Yoo SA, Bae DG, Ryoo JW, Kim HR, Park GS, Cho CS, Chae CB, Kim WU (2005) Arginine-rich antivascular endothelial growth factor (anti-VEGF) hexapeptide inhibits collagen-induced arthritis and VEGF-stimulated productions of TNF-alpha and IL- 6 by human monocytes. J Immunol 174:5846-5855
35. Lee TH, Avraham H, Lee SH, Avraham S (2002) Vascular endothelial growth factor modulates neutrophil transendothelial migration via upregulation of interleukin-8 in human brain microvascular endothelial cells. J Biol Chem 277:10445-10451
36. Badylak SF, Gilbert TW (2008) Immune response to biologic scaffold materials. Semin Immunol 20:109-116
37. Gilbert TW, Sellaro TL, Badylak SF (2006) Decellularization of tissues and organs. Biomaterials 27:3675-3683
38. Blackwood KA, McKean R, Canton I, Freeman CO, Franklin KL, Cole D, Brook I, Farthing P, Rimmer S, Haycock JW, Ryan AJ, MacNeil S (2008) Development of biodegradable electrospun scaffolds for dermal replacement. Biomaterials 29:3091-3104